Loxapine succinate - CAS# 27833-64-3 oxy)-1 6-dihydroxy-2-methyl-9 10-anthracenedione InChi: InChI=1S/C16H18O10/c1-23-7-4-6-2-3-9(18)25-14(6)15(11(7)20)26-16-13(22)12(21)10(19)8(5-17)24-16/h2-4

InChi: InChI=1S/C16H18O10/c1-23-7-4-6-2-3-9(18)25-14(6)15(11(7)20)26-16-13(22)12(21)10(19)8(5-17)24-16/h2-4

uu value of 1

InChi: InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16

Vicriviroc represents a promising new candidate for the treatment of HIV-1 infection

and suppresses carotid artery lipid accumulation

Loxapine succinate - CAS# 27833-64-3 oxy)-1 6-dihydroxy-2-methyl-9 10-anthracenedione InChi: InChI=1S/C16H18O10/c1-23-7-4-6-2-3-9(18)25-14(6)15(11(7)20)26-16-13(22)12(21)10(19)8(5-17)24-16/h2-4Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti psychotic agent. IC50 value: Target: D2DR D4DR; 5 HT receptor in vitro: In the presence of Loxapine, [3H]ketanserin binds to 5 HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6. 2 nM and 6. 6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows: 5